| Report Title | Price | Action |
|---|---|---|
| Interleukin 7 (IL7) - Drugs in Development, 2021
Interleukin 7 (IL7) - Drugs in Development, 2021 Summary Interleukin 7 (IL7) - Drugs in Development, 2021 provides in depth analysis on Interleukin ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021 Summary T-Cell Acute Lymphocytic Le...
Published: Apr-2021 | No. of Pages: 80
|
$ 2000 | |
| Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021
Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021 Summary Mycobacterium avium Infections (Infectious Disease) - Drugs...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021
Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021 Summary Citrullinemia Type I (Arginosu...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) - Drugs in Development, 2021
Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) - Drugs in Development, 2021 Summary Ribonucleoside Diphosphat...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) - Drugs in Development, 2021
Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) - Drugs in Development, 2021 Summary Ke...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) (Oncology) - Drugs in Development, 2021
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) (Oncology) - Drugs in Development, 2021 Summary Post-Essential Thrombocythemia Myelofibros...
Published: Apr-2021 | No. of Pages: 80
|
$ 2000 | |
| Pseudomonas Infections (Infectious Disease) - Drugs in Development, 2021
Pseudomonas Infections (Infectious Disease) - Drugs in Development, 2021 Summary Pseudomonas Infections (Infectious Disease) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Cystinuria (Genetic Disorders) - Drugs in Development, 2021
Cystinuria (Genetic Disorders) - Drugs in Development, 2021 Summary Cystinuria (Genetic Disorders) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| T Cell Immunoreceptor With Ig And ITIM Domains (V Set And Immunoglobulin Domain Containing Protein 9 or V Set And Transmembrane Domain Containing Protein 3 or TIGIT) - Drugs in Development, 2021
T Cell Immunoreceptor With Ig And ITIM Domains (V Set And Immunoglobulin Domain Containing Protein 9 or V Set And Transmembrane Domain Containing Prot...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs in Development, 2021
Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs in Development, 2021 Summary Kynurenine 3 Monooxygenase (Kynure...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021
Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021 Summary Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 80
|
$ 2000 | |
| Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021
Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 Summary Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021
Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021 Summary Gaucher Disease Type II (Genetic Disorders) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Bile Acid Receptor (Farnesoid X Activated Receptor or Farnesol Receptor HRR 1 or Nuclear Receptor Subfamily 1 Group H Member 4 or Retinoid X Receptor Interacting Protein 14 or FXR or NR1H4) - Drugs in Development, 2021
Bile Acid Receptor (Farnesoid X Activated Receptor or Farnesol Receptor HRR 1 or Nuclear Receptor Subfamily 1 Group H Member 4 or Retinoid X Receptor ...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021
Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 Summary Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24)...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021
Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021 Summary Large Conductance Mechanosensitive Channel (mscL) - Drugs in ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Transplant Rejection (Immunology) - Drugs in Development, 2021
Transplant Rejection (Immunology) - Drugs in Development, 2021 Summary Transplant Rejection (Immunology) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 80
|
$ 2000 | |
| Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021
Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021 Summary Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021
Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 Summary Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs i...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 |